Quality of life in pressurised intraperitoneal aerosolised chemotherapy

This project aims to explore the views and experiences of patients with peritoneal metastases (cancer that has spread to the lining of the abdomen), who are undergoing pressurised intraperitoneal aerosol chemotherapy (PIPAC).

PIPAC is a new chemotherapy delivery method. It allows a surgeon to spray chemotherapy directly onto the cancer that has spread into the lining of the abdomen, which they do during keyhole surgery.

During the study we will speak with healthcare professionals and patients who are taking part in the PICCOS (PIPAC in Cancers of the Colon, Ovaries and Stomach) trial to:

• Explore and understand their views of PIPAC treatment
• Understand how treatment with PIPAC affects patients’ symptoms and quality of life

This will allow us to:

• Explore the impact PIPAC has on patient’s symptoms and their quality of life
• Determine if existing ways of assessing quality of life among patients also measure PIPAC-specific issues
• Potentially develop a new way of measuring PIPAC-specific quality of life issues

Our study is part of a the PICCOS trial sponsored by Cardiff and Vale University Health Board and funded by the National Institute for Health and Care Research (NIHR).